About this trial
The study aims to map sleep disorders and their impact on the ability to engage in an active daily life among people who have had a stroke, with particular focus on how sleep apnea can be identified.
The study has the following objectives:
1. To examine the occurrence of sleep apnea, insomnia, excessive daytime sleepiness, and restless legs syndrome/periodic limb movements in patients with ischemic stroke three months after onset. 2. To investigate associations between these sleep disorders and physical and mental health, fatigue, quality of life, cognitive and physical function, and daily physical behavior including physical activity levels. 3. To identify which clinical factors and patient reported data, including patient reported data from commercial wearable health technology, predict a diagnosis of sleep apnea. 4. To examine how sleep disorders affect changes in physical and mental health, fatigue, quality of life, cognitive and physical function, and daily physical behavior including physical activity levels one year after stroke.
Eligibility criteria
Qualifiers
Ischemic stroke.
First time stroke.
Disqualifiers
Short expected survival.
Unable to carry HSAT equipment (e.g., gel nails; the patient is wearing other medical devices; motor or cognitive impairment without the possibility of assistance from healthcare staff or relatives).
Reduced understanding of the project due to insufficient Swedish, which cannot be bridged with an interpreter.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Malin Eleonora av Kák Gustafsson, MD, PhD
Lead sponsor
Region Skane
Sponsor institution
Region Skane
Collaborator
Lund University
Collaborator